人乳头瘤病毒 (HPV) 新型护理点诊断测试的评估
To learn if new HPV tests can provide the same results as standard HPV tests. The findings from this study may aid in the development of new HPV tests that require less equipment and are more accessible.
研究概览
地位
条件
详细说明
Primary Objectives
1. To evaluate the performance of 3 versions of a novel point-of-care diagnostic test for detecting HPV ("Rice HPV test").
Secondary Objectives
- To evaluate the results of the Rice HPV test with corresponding pathology results to assess the association of HPV test results with the presence of high-grade cervical dysplasia (CIN 2+).
- To assess how different sample processing methods affect the performance of the Rice HPV test.
- To assess how different test readout methods affect the performance of the Rice HPV test.
Exploratory Objectives
- Compare the performance of the Rice HPV test between provider-collected and self-collected samples.
- Conduct a survey on participant experiences with self-sampling to assess whether participants prefer self-sampling over provider-collected sampling.
- Compare the performance of the Rice HPV test to other benchmark HPV tests such as GeneXpert.
研究类型
注册 (估计的)
联系人和位置
学习联系方式
- 姓名:Kathleen Schmeler, MD
- 电话号码:(713) 745-3518
- 邮箱:kschmele@mdanderson.org
学习地点
-
-
Texas
-
Houston、Texas、美国、77030
- 招聘中
- MD Anderson Cancer Center
-
首席研究员:
- Kathleen Schmeler, MD
-
接触:
- Kathleen Schmeler, MD
- 电话号码:(713) 745-3518
- 邮箱:kschmele@mdanderson.org
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
取样方法
研究人群
MD Anderson Cancer Center
描述
Inclusion Criteria:
- People with a cervix 21 years of age or older.
- Scheduled to undergo hrHPV testing at MD Anderson and The Harris Health System (LBJ Hospital) according to national and institutional guidelines at time of enrollment OR are anticipated to undergo a LEEP, ECC, or biopsy.
- Willing and able to provide informed consent.
- Able to perform protocol-required activities. Able to speak and read English or Spanish.
Exclusion Criteria
- Patient or provider decision not to perform HPV testing. This does not apply to patients that are undergoing either a LEEP, ECC or biopsy.
- Participant or provider decision not to collect a sample for this study.
- Participants that are pregnant.
学习计划
研究是如何设计的?
设计细节
- 观测模型:CASE_ONLY
- 时间观点:CROSS_SECTIONAL
队列和干预
团体/队列 |
干预/治疗 |
|---|---|
|
Research Group
Standard-of-care (SOC) procedures will be performed as part of the routine visit, and the provider will collect up to two additional cervical swabs for research. One research cervicovaginal swab may also be self-collected by the patient (optional procedure) in the clinic during the routine visit. All research swab samples, in addition to residual material from standard of care HPV testing, will be transferred to Rice University team for testing and some will be tested on site at the provider facility as described below. |
Given by Diagnostic Test |
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Novel point-of-care diagnostic test for detecting HPV ("Rice HPV test")
大体时间:Through study completion; an average of 1 year
|
To evaluate the performance of the 3 version of a novel point-of-care diagnostic test for detecting HPV ("Rice HPV test"). |
Through study completion; an average of 1 year
|
合作者和调查者
调查人员
- 首席研究员:Kathleen Schmeler, MD、M.D. Anderson Cancer Center
出版物和有用的链接
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
其他研究编号
- 2024-0020
- NCI-2024-04598 (其他标识符:NCI-CTRP Clinical Registry)
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
在美国制造并从美国出口的产品
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.